Danggui Beimu Kushen Pill Alleviates Colitis-Induced Inflammation in Mice by Regulating the IL-6/IL-6R and IL-17A/IL-17RA Signaling Pathways

Danggui Beimu Kushen Pill Alleviates Colitis-Induced Inflammation in Mice by Regulating the IL-6/IL-6R and IL-17A/IL-17RA Signaling Pathways

<b>Background/Objectives</b>: Danggui Beimu Kushen pill (DBK) is a traditional Chinese medicine renowned for its efficacy in the treatment of inflammatory conditions. It has been used in the modern clinical treatment of ulcerative colitis (UC). Further research is required to clarify its...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuo Gong, Ran Xu, Yuqing Wang, Shangling Mao, Yi Zhang, Qingru Bu, Ruotong Yang, Tianming Wang, Yue Yang
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pharmaceuticals
Subjects:
Danggui Beimu Kushen pill
ulcerative colitis
interleukin-6
interleukin-17
Th17
Online Access:https://www.mdpi.com/1424-8247/18/2/141
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/2/141

Similar Items